Metformin and cancer mortality
The author analyses recent publications supporting the ability of metformin to decrease the risk of cancer morbidity and mortality in patients with type 2diabetes mellitus. Pre-history of the problem (including the use of biguanides for metabolic rehabilitation of oncological patients), the role of...
Guardado en:
Autor principal: | Lev Mikhaylovich Bershteyn |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05da729af1a04fbb8decb7c01a66bd6a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
por: Lev Mikhaylovich Bershteyn, et al.
Publicado: (2014) -
Multidimensional effects of metformin in patients with type 2 diabetes
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2017) -
Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
por: Anna I. Sazonova, et al.
Publicado: (2016) -
Diabetes, obesity and cancer: risk and anti-risk factors
por: Lev Mikhaylovich Bershteyn
Publicado: (2012) -
Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
por: Natalya Vladislavovna Zaytseva, et al.
Publicado: (2015)